Providing Domestic and International Rare Cancer Information and Connecting Patients with Medical Professionals

The Rare Cancer Research Project Group at the National Cancer Center announced on April 3 that it has officially launched the "Rare Cancer Information Portal," which aims to provide accurate health information to rare cancer patients and their families and support connections with specialized medical professionals.


Rare Cancer Information Portal Screen. National Cancer Center.

Rare Cancer Information Portal Screen. National Cancer Center.

View original image

Because the incidence rates of individual rare cancers are low, patients have often struggled to find reliable information during the diagnosis and treatment process. In particular, many patients obtain limited and unverified information from internet searches or online communities, highlighting the need for a trustworthy information platform.


In response, the National Cancer Center built the new portal by referencing public rare disease information services such as the Genetic and Rare Diseases Information Center (GARD) under the National Institutes of Health (NIH) in the United States, and by collaborating with domestic rare cancer research groups.


The Rare Cancer Information Portal offers a wide range of services, including: ▲ searching for rare cancer disease information and linking to clinical trial information ▲ information on patient support groups and communities ▲ searching for specialized medical professionals and hospitals ▲ online consultation (Q&A) services. In addition, it includes a donation system connected to the National Cancer Center’s development fund, with the goal of encouraging broader social interest in rare cancer treatment.


The National Cancer Center explained that the significance of this portal goes beyond simply providing information. It meaningfully addresses information disparities among rare cancer patients, enhances connections to specialized medical professionals, and expands opportunities for participation in clinical research, thereby drastically improving access to medical services from multiple perspectives.


Going forward, the Rare Cancer Research Project Group at the National Cancer Center plans to strengthen its cooperation with the domestic rare cancer research network, systematically accumulate big data on rare cancers, and focus on advancing its information system based on artificial intelligence (AI). Through these efforts, the goal is to substantially improve the medical environment so that rare cancer patients can receive precision diagnoses and be quickly guided to optimal treatment pathways at a global standard.



Junhyuk Kim, Head of the Rare Cancer Research Project Group and Director of the Sarcoma Center at the National Cancer Center, stated, "We launched this portal to address the reality that rare cancer patients have had to seek out accurate disease information through multiple channels," adding, "We will continue to serve as a patient-centered public platform and play a central role in connecting rare cancer care and research."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing